Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries

Heart Rhythm

Volumn 6, Issue 9, 2009, Pages 1267-1273

  Ellis, Ethan R ^a   Culler, Steven D ^b   Simon, April W ^c   Reynolds, Matthew R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c Cardiac Data Solutions Inc   (United States)

Author keywords

Ablation; Atrial fibrillation; Complication; Medicare; Pulmonary vein isolation

Indexed keywords

ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; CARDIAC PATIENT; CATHETER ABLATION; CONTROLLED STUDY; DEATH; FEMALE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART INJURY; HEART TAMPONADE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PNEUMOTHORAX; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; UTILIZATION REVIEW; VASCULAR ACCESS; VASCULAR SURGERY; ATRIAL FIBRILLATION; CONFIDENCE INTERVAL; ECONOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CATHETER ABLATION; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 68949217027     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.06.009     Document Type: Article

References (19)

1. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 (2006) 119-125
2. Spragg D.D., Dalal D., Cheema A., et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol 19 (2008) 627-631
3. Cheema A., Vasamreddy C.R., Dalal D., et al. Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 15 (2006) 145-155
4. Oral H., Pappone C., Chugh A., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 354 (2006) 934-941
5. Ouyang F., Ernst S., Chun J., et al. Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique. Circulation 112 (2005) 3038-3048
6. Wazni O.M., Marrouche N.F., Martin D.O., et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293 (2005) 2634-2640
7. Calkins H., Brugada J., Packer D.L., et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm 4 (2007) 816-861
8. Noheria A., Kumar A., Wylie Jr. J.V., and Josephson M.E. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med 168 (2008) 581-586
9. Quan H., Parsons G.A., and Ghali W.A. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 40 (2002) 675-685
10. Cummings J.E., Schweikert R.A., Saliba W.I., et al. Brief Communication: atrial-esophageal fistulas after radiofrequency ablation. Ann Intern Med 144 (2006) 572-574
11. Cappato R., Calkins H., Chen S.A., et al. World-wide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111 (2005) 1100-1105
12. Bertaglia E., Zoppo F., Tondo C., et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. Heart Rhythm 4 (2007) 1265-1271
13. Jais P., Cauchemez B., Macle L., et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 Study. Circulation 118 (2008) 2498-2505
14. Pappone C., Augello G., Sala S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. J Am Coll Cardiol 48 (2006) 2340-2347
15. Stabile G., Bertaglia E., Senatore G., et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J 27 (2006) 216-221
16. Zado E., Callans D.J., Riley M., et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol 19 (2008) 621-626
17. Cohen D.J., Lincoff A.M., Lavelle T.A., et al. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. J Am Coll Cardiol 44 (2004) 1792-1800
18. Culler S.D., Simon A.W., Brown P.P., Kugelmass A.D., Reynolds M.R., and Rask K.J. Gender differences in hospital risk-adjusted mortality rates for Medicare beneficiaries. Arch Intern Med 168 (2008) 2317-2322
19. Gurm H.S., Whitlow P.L., and Kip K.E. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 39 (2002) 834-840